Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Gijon – page 4

57 clinical trials in Gijon, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Gijon at a glance
57
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

57 trials in Gijon

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:La Fundacion Para La Gestion De La Investigacion Biomedica De Cadiz
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Fundacion PETHEMA
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:GWT-Tud GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen - Cilag International

Follicular lymphoma

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Cardiac amyloidosis+1

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anselamimab
  • Sponsor:Alexion Pharmaceuticals Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anselamimab
  • Sponsor:Alexion Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belantamab Mafodotin
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Gijon

What the registry says about research in the country

01 Hematologic Malignancies

Extensive research focusing on multiple myeloma and various lymphomas, including innovative combination therapies and novel treatment approaches for previously untreated and relapsed/refractory cases.

  • Mantle Cell Lymphoma
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia

Studies evaluating breakthrough treatments like acalabrutinib, belantamab mafodotin, and linvoseltamab.

02 Gastrointestinal Disorders

Clinical investigations targeting various digestive system conditions, with particular emphasis on pancreatic diseases and inflammatory bowel conditions.

  • Ulcerative Colitis
  • Pancreatic Adenocarcinoma
  • Biliary Pancreatitis

Research includes both therapeutic interventions and surgical approaches for optimal patient outcomes.

03 Cardiovascular Research

Innovative studies examining treatments for coronary artery conditions and vascular events, with focus on both preventive measures and therapeutic interventions.

  • Spontaneous Coronary Artery Dissection
  • Antiplatelet Therapy
  • Chronic Renal Disease

Investigations into beta-blockers, antiplatelet agents, and colchicine for various cardiovascular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.